LEADER 01197nam  2200265z- 450 
001 9910694044903321
005 20060622161110.0
035   $a(CKB)5860000000026283
035   $a(BIP)013650130
035   $a(EXLCZ)995860000000026283
100   $a20220406c2006uuuu  -u-         -
101 0 $aeng
200 14$aThe impact of direct-to-consumer drug advertising on seniors' health and health care costs $ehearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, September 29, 2005
215   $a1 online resource (iii, 124 p.) $cill
311   $a0-16-075908-0 
517   $aImpact of direct-to-consumer drug advertising on seniors' health and health care costs 
606   $aDirect-to-consumer prescription drug advertising$zUnited States
610   $aAdvertising
610   $aBusiness & economics
615  0$aDirect-to-consumer prescription drug advertising
712 02$aUnited States, Congress Senate Special Committee on Aging Staff,$4oth
906   $aBOOK
912   $a9910694044903321
996   $aThe impact of direct-to-consumer drug advertising on seniors' health and health care costs$93120899
997   $aUNINA